Internal Medicine, Infectious Disease · Tampa, FL
NPI
1174506703
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4729 N Habana Ave
Tampa, FL, 33614
Phone (813) 251-8444
Groups this clinician bills Medicare through
Medicare paid, 2024
$198K
86,696 services
Medicare patients, 2024
583
Average age 73
Drug cost, 2024
$2.6M
1,603 prescriptions
Company payments, 2025
$2,265
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nadeem R Khan was code J0878 (injection, daptomycin, 1 mg), 79,000 times for 13 patients. In total Nadeem R Khan billed 86,696 services in 41 codes, and Medicare paid $198K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0878 Injection, daptomycin, 1 mg | Office | 79,000 | 13 | $0.03 | $2,762 |
| 99232 Hospital E&M - Subsequent | Facility | 1,527 | 396 | $59.78 | $91K |
| J1335 Injection, ertapenem sodium, 500 mg | Office | 546 | 17 | $9.35 | $5,106 |
| 99222 Hospital E&M - Initial | Facility | 425 | 360 | $99.24 | $42K |
| 96365 Intravenous Infusion, Hydration | Office | 410 | 32 | $46.82 | $19K |
| 99213 Office E&M - Established | Office | 188 | 116 | $64.48 | $12K |
| 99233 Hospital E&M - Subsequent | Facility | 103 | 42 | $87.09 | $8,971 |
| 36415 Venipuncture Blood Collection | Office | 49 | 37 | $8.47 | $415 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 32 | 29 | $76.34 | $2,443 |
| 99212 Office E&M - Established | Office | 27 | 24 | $38.39 | $1,037 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 14 | $11.96 | $179 |
| 99204 Office E&M - New | Office | 11 | 11 | $130.52 | $1,436 |
By year: 2022 $259K for 90,106 services; 2023 $245K for 38,170 services; 2024 $198K for 86,696 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 49 | 37 | $8.47 | $415 |
Medicare prescription drug claims, 2024
In 2024, the drug Nadeem R Khan prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 253 prescriptions and refills. In total Nadeem R Khan wrote 1,603 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 253 | 263 | 27 | $1.1M |
| Daptomycin Generic | 73 | 73 | 18 | $26K |
| Cefepime Hcl Generic | 72 | 72 | 19 | $8,645 |
| Dovato Dolutegravir Sodium/Lamivudine | 61 | 61 | Under 11 | $178K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 61 | 65 | 18 | $414 |
| Doxycycline Hyclate Generic | 57 | 73 | 26 | $1,653 |
| Vancomycin Hcl Generic | 51 | 51 | 17 | $8,548 |
| Ceftriaxone Ceftriaxone Sodium | 47 | 47 | 13 | $3,744 |
| Ciprofloxacin Hcl Generic | 46 | 48 | 26 | $869 |
| Cephalexin Generic | 42 | 42 | Under 11 | $385 |
| Meropenem Generic | 39 | 39 | Under 11 | $9,778 |
| Tivicay Dolutegravir Sodium | 37 | 37 | Under 11 | $82K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 37 | 37 | Under 11 | $180K |
| Descovy Emtricitabine/Tenofov Alafenam | 37 | 37 | Under 11 | $80K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 35 | 35 | Under 11 | $152K |
Brand drugs: 700 claims; generic drugs: 903 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nadeem R Khan $2,265 ($2,265 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $443.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 17 | $443 |
| ViiV Healthcare Company GSK | 17 | $391 |
| Merck Sharp & Dohme LLC MRK | 12 | $271 |
| Gilead Sciences, Inc. GILD | 12 | $248 |
| Insmed, Inc. INSM | 6 | $164 |
| Linvatec Corporation CNMD | 1 | $154 |
| Paratek Pharmaceuticals, Inc. | 8 | $136 |
| Melinta Therapeutics, LLC | 5 | $118 |
| Shionogi Inc 4507.T | 4 | $87.86 |
| La Jolla Pharmaceutical Company | 3 | $86.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.